The impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms.
about
Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?FROGG high-risk prostate cancer workshop: patterns of practice and literature review: part I: intact prostate.Prostate cancer nomograms: a review of their use in cancer detection and treatment.Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer.Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate CancerSalvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review.Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients.Prostate cancer: stratifying intermediate-risk patients for radiotherapy.Effects of dose-escalated radiotherapy in combination with long-term androgen deprivation on prostate cancer.Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.
P2860
Q36726123-FFF9BD36-4F15-4EDF-BB4A-E8168D89B47FQ36908059-8F975888-D1E8-4165-BF39-8BA05E0C80BEQ38168635-3E62A52A-6E31-4055-906A-FC88DAAA4A67Q38181000-C3A21418-E9F2-4567-8145-20E033EE4D86Q38375214-C905EAC9-D477-4F02-911A-DAA8A71D12BDQ38984178-BEEBB687-5AEE-4CCE-99F0-01C39FA15E86Q39422186-1491B39B-4C37-4932-B7E1-6891194E6D91Q42687909-CE51DC20-6B08-47B2-B144-CBD4BFC7F776Q44592335-9CBFF2BD-22AE-48AB-87DC-30CF6DA8E122Q49803982-4120762C-37A4-402A-9DAA-B618B0BF3942Q51904524-3E683D73-3343-4BD6-A71F-166BEE5BAF7A
P2860
The impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The impact of dose-escalated r ...... ncer using 2 linked nomograms.
@ast
The impact of dose-escalated r ...... ncer using 2 linked nomograms.
@en
type
label
The impact of dose-escalated r ...... ncer using 2 linked nomograms.
@ast
The impact of dose-escalated r ...... ncer using 2 linked nomograms.
@en
prefLabel
The impact of dose-escalated r ...... ncer using 2 linked nomograms.
@ast
The impact of dose-escalated r ...... ncer using 2 linked nomograms.
@en
P2093
P2860
P356
P1433
P1476
The impact of dose-escalated r ...... ancer using 2 linked nomograms
@en
P2093
Alan Pollack
David Y T Chen
Eric M Horwitz
Mark K Buyyounouski
Niraj H Pahlajani
Radka Stoyanova
P2860
P304
P356
10.1002/CNCR.27857
P407
P577
2012-10-23T00:00:00Z